The price of global health: drug pricing strategies to balance patient access and the funding of innovation
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Farnham, Surrey ; Burlington, VT
Gower
[2015]
|
| Ausgabe: | Second edition |
| Schlagworte: | |
| Online-Zugang: | TUM01 |
| Beschreibung: | Vendor-supplied metadata |
| Beschreibung: | 1 online resource |
| ISBN: | 9781472438812 1472438817 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044358765 | ||
| 003 | DE-604 | ||
| 005 | 20180221 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170620s2015 |||| o||u| ||||||eng d | ||
| 020 | |a 9781472438812 |9 978-1-4724-3881-2 | ||
| 020 | |a 1472438817 |9 1-4724-3881-7 | ||
| 035 | |a (ZDB-4-NLEBK)ocn895254696 | ||
| 035 | |a (OCoLC)895254696 | ||
| 035 | |a (DE-599)BVBBV044358765 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-91 | ||
| 082 | 0 | |a 338.4/36151 |2 23 | |
| 100 | 1 | |a Schoonveld, Ed |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a The price of global health |b drug pricing strategies to balance patient access and the funding of innovation |c Ed Schoonveld |
| 250 | |a Second edition | ||
| 264 | 1 | |a Farnham, Surrey ; Burlington, VT |b Gower |c [2015] | |
| 264 | 4 | |c © 2015 | |
| 300 | |a 1 online resource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Vendor-supplied metadata | ||
| 505 | 8 | |a The drug pricing challenge -- Payers -- Fundamentals of pricing -- Reference based pricing -- Health outcomes and health economics -- Features, benefits, value and price -- Pricing and drug development -- Payer segmentation -- Key situation factors : the podium approach -- The best price framework to pricing and market access -- Payer value story -- Developing a global pricing strategy -- Public policy and ethical considerations -- Oncology and orphan drugs -- Payer and pricing research -- Corporate market access and pricing function -- Market access and pricing negotiations -- Risk sharing and managed entry agreements -- United states -- Canada -- France -- Germany -- Italy -- Spain -- UK -- Japan -- Australia -- Brazil -- China -- India -- South korea | |
| 650 | 7 | |a BUSINESS & ECONOMICS / Industries / General |2 bisacsh | |
| 650 | 7 | |a Drugs / Prices |2 fast | |
| 650 | 7 | |a Globalization |2 fast | |
| 650 | 7 | |a Medical care |2 fast | |
| 650 | 7 | |a Pharmaceutical industry / Prices |2 fast | |
| 650 | 4 | |a Globalisierung | |
| 650 | 4 | |a Industrie | |
| 650 | 4 | |a Wirtschaft | |
| 650 | 4 | |a Drugs |x Prices |a Pharmaceutical industry |x Prices |a Medical care |a Globalization | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Schoonveld, Ed |t Price of global health : drug pricing strategies to balance patient access and the funding of innovation |d Farnham, Surrey : Gower, [2015] |z 9781472438805 |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029761396 | ||
| 966 | e | |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=844618 |l TUM01 |p ZDB-4-NLEBK |q TUM_PDA_EBSCOBAE_Kauf |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804177604814569472 |
|---|---|
| any_adam_object | |
| author | Schoonveld, Ed |
| author_facet | Schoonveld, Ed |
| author_role | aut |
| author_sort | Schoonveld, Ed |
| author_variant | e s es |
| building | Verbundindex |
| bvnumber | BV044358765 |
| collection | ZDB-4-NLEBK |
| contents | The drug pricing challenge -- Payers -- Fundamentals of pricing -- Reference based pricing -- Health outcomes and health economics -- Features, benefits, value and price -- Pricing and drug development -- Payer segmentation -- Key situation factors : the podium approach -- The best price framework to pricing and market access -- Payer value story -- Developing a global pricing strategy -- Public policy and ethical considerations -- Oncology and orphan drugs -- Payer and pricing research -- Corporate market access and pricing function -- Market access and pricing negotiations -- Risk sharing and managed entry agreements -- United states -- Canada -- France -- Germany -- Italy -- Spain -- UK -- Japan -- Australia -- Brazil -- China -- India -- South korea |
| ctrlnum | (ZDB-4-NLEBK)ocn895254696 (OCoLC)895254696 (DE-599)BVBBV044358765 |
| dewey-full | 338.4/36151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/36151 |
| dewey-search | 338.4/36151 |
| dewey-sort | 3338.4 536151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| edition | Second edition |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02618nmm a2200481zc 4500</leader><controlfield tag="001">BV044358765</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180221 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170620s2015 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781472438812</subfield><subfield code="9">978-1-4724-3881-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1472438817</subfield><subfield code="9">1-4724-3881-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-NLEBK)ocn895254696</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)895254696</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044358765</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/36151</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schoonveld, Ed</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The price of global health</subfield><subfield code="b">drug pricing strategies to balance patient access and the funding of innovation</subfield><subfield code="c">Ed Schoonveld</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Farnham, Surrey ; Burlington, VT</subfield><subfield code="b">Gower</subfield><subfield code="c">[2015]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Vendor-supplied metadata</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">The drug pricing challenge -- Payers -- Fundamentals of pricing -- Reference based pricing -- Health outcomes and health economics -- Features, benefits, value and price -- Pricing and drug development -- Payer segmentation -- Key situation factors : the podium approach -- The best price framework to pricing and market access -- Payer value story -- Developing a global pricing strategy -- Public policy and ethical considerations -- Oncology and orphan drugs -- Payer and pricing research -- Corporate market access and pricing function -- Market access and pricing negotiations -- Risk sharing and managed entry agreements -- United states -- Canada -- France -- Germany -- Italy -- Spain -- UK -- Japan -- Australia -- Brazil -- China -- India -- South korea</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS / Industries / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Prices</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Globalization</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medical care</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry / Prices</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Globalisierung</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wirtschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Prices</subfield><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Prices</subfield><subfield code="a">Medical care</subfield><subfield code="a">Globalization</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Schoonveld, Ed</subfield><subfield code="t">Price of global health : drug pricing strategies to balance patient access and the funding of innovation</subfield><subfield code="d">Farnham, Surrey : Gower, [2015]</subfield><subfield code="z">9781472438805</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029761396</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=844618</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCOBAE_Kauf</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV044358765 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:50:43Z |
| institution | BVB |
| isbn | 9781472438812 1472438817 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029761396 |
| oclc_num | 895254696 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 online resource |
| psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCOBAE_Kauf |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | Gower |
| record_format | marc |
| spelling | Schoonveld, Ed Verfasser aut The price of global health drug pricing strategies to balance patient access and the funding of innovation Ed Schoonveld Second edition Farnham, Surrey ; Burlington, VT Gower [2015] © 2015 1 online resource txt rdacontent c rdamedia cr rdacarrier Vendor-supplied metadata The drug pricing challenge -- Payers -- Fundamentals of pricing -- Reference based pricing -- Health outcomes and health economics -- Features, benefits, value and price -- Pricing and drug development -- Payer segmentation -- Key situation factors : the podium approach -- The best price framework to pricing and market access -- Payer value story -- Developing a global pricing strategy -- Public policy and ethical considerations -- Oncology and orphan drugs -- Payer and pricing research -- Corporate market access and pricing function -- Market access and pricing negotiations -- Risk sharing and managed entry agreements -- United states -- Canada -- France -- Germany -- Italy -- Spain -- UK -- Japan -- Australia -- Brazil -- China -- India -- South korea BUSINESS & ECONOMICS / Industries / General bisacsh Drugs / Prices fast Globalization fast Medical care fast Pharmaceutical industry / Prices fast Globalisierung Industrie Wirtschaft Drugs Prices Pharmaceutical industry Prices Medical care Globalization Erscheint auch als Druck-Ausgabe Schoonveld, Ed Price of global health : drug pricing strategies to balance patient access and the funding of innovation Farnham, Surrey : Gower, [2015] 9781472438805 |
| spellingShingle | Schoonveld, Ed The price of global health drug pricing strategies to balance patient access and the funding of innovation The drug pricing challenge -- Payers -- Fundamentals of pricing -- Reference based pricing -- Health outcomes and health economics -- Features, benefits, value and price -- Pricing and drug development -- Payer segmentation -- Key situation factors : the podium approach -- The best price framework to pricing and market access -- Payer value story -- Developing a global pricing strategy -- Public policy and ethical considerations -- Oncology and orphan drugs -- Payer and pricing research -- Corporate market access and pricing function -- Market access and pricing negotiations -- Risk sharing and managed entry agreements -- United states -- Canada -- France -- Germany -- Italy -- Spain -- UK -- Japan -- Australia -- Brazil -- China -- India -- South korea BUSINESS & ECONOMICS / Industries / General bisacsh Drugs / Prices fast Globalization fast Medical care fast Pharmaceutical industry / Prices fast Globalisierung Industrie Wirtschaft Drugs Prices Pharmaceutical industry Prices Medical care Globalization |
| title | The price of global health drug pricing strategies to balance patient access and the funding of innovation |
| title_auth | The price of global health drug pricing strategies to balance patient access and the funding of innovation |
| title_exact_search | The price of global health drug pricing strategies to balance patient access and the funding of innovation |
| title_full | The price of global health drug pricing strategies to balance patient access and the funding of innovation Ed Schoonveld |
| title_fullStr | The price of global health drug pricing strategies to balance patient access and the funding of innovation Ed Schoonveld |
| title_full_unstemmed | The price of global health drug pricing strategies to balance patient access and the funding of innovation Ed Schoonveld |
| title_short | The price of global health |
| title_sort | the price of global health drug pricing strategies to balance patient access and the funding of innovation |
| title_sub | drug pricing strategies to balance patient access and the funding of innovation |
| topic | BUSINESS & ECONOMICS / Industries / General bisacsh Drugs / Prices fast Globalization fast Medical care fast Pharmaceutical industry / Prices fast Globalisierung Industrie Wirtschaft Drugs Prices Pharmaceutical industry Prices Medical care Globalization |
| topic_facet | BUSINESS & ECONOMICS / Industries / General Drugs / Prices Globalization Medical care Pharmaceutical industry / Prices Globalisierung Industrie Wirtschaft Drugs Prices Pharmaceutical industry Prices Medical care Globalization |
| work_keys_str_mv | AT schoonvelded thepriceofglobalhealthdrugpricingstrategiestobalancepatientaccessandthefundingofinnovation |